The ASCO Post
News and views from the world of clinical oncology and hematology
- 🏥 American College of Surgeons released its annual National Cancer Database report, showing a major rise in neoadjuvant systemic therapy across cancer types—helping shrink tumors, guiding treatment decisions, & enabling less invasive surgery. Read key takeaways 👉 ow.ly/iqfp50Y8NI7
- 🗣️ Matthew Strickland, MD, discusses phase IIb TERRIFIC data evaluating neoadjuvant tislelizumab + chemoradiotherapy vs chemo(radio)therapy for patients with locally advanced gastric/GEJ adenocarcinoma. 🎥 Watch the video: ow.ly/LcNf50Y7JNK
